Skip to main content

Biocom Annual “Celebration of Life” Dinner

When:

November 21, 2019 4:00 pmNovember 21, 2019 8:30 pm (PST)

Where:

Hyatt Regency La Jolla
3777 La Jolla Village Drive
San Diego, California 92122

Registration Closed

Imagine this…

An invisible world of microorganisms brought to light by researchers, charted by technology, and turned into discoveries by pioneers like you…

Discoveries that recognize diseases, pinpoint treatments, optimize medicines and identify cures. Discoveries that secure a better future for our children and challenge them to take us further…

To democratize the future of medicine, to empower every individual and to turn that same world of microorganisms into renewable biofuels that can propel us forward into the future of We.

Imagine this: a world without limits.

Bring your imagination to Biocom’s Annual Celebration of Life Dinner on November 21st, 2019 at the Hyatt Regency La Jolla At Aventine where we’ll recognize life science achievements from the past year and set the stage for a limitless 2020.

Keynote Speaker: Gay Grossman

Gay has been active in the Rare Disease community for over two decades and continues her efforts to build and support patient and family advocacy. Ten years ago, when she first spoke, she was the mother of a 12 year old daughter without a diagnosis. She shared her daughter’s experience of being physically disabled in a typical world. Soon the subject changed to how she and her husband made accommodations in schools and how they learned about the science which might someday be available and lead them to a diagnosis.

Finally in 2013, Gay was able to speak about the experience of getting a genetic diagnosis through whole genome sequencing, after not having a diagnosis for 15 years.

Today her daughter is an adult and does her own advocacy. Gay has recently looked in the mirror and changed her speaking subject to her own Rare Disease experience of being a mother, the primary caregiver, and what it was like to live and love her daughter not knowing what was wrong. Together, Gay and her husband have built a dedicated team who help them keep the science moving towards a treatment. Together they founded ADCY5.org, the foundation for ADCY5-related dyskinesia. They are advocates of shared data and patients owning their data. They maintain their focus to help all Rare Disease patients. Due to their work, this foundation now supports world-renowned researchers who study the gene, while they continue to build a community of hundreds, when they started with only 1.

Gay is currently the Director of Patient Engagement at Neurogene Inc.


FDA Spotlight: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs U.S. Food and Drug Administration


Anna Abram is Deputy Commissioner for Policy, Legislation, and International Affairs for the U.S. Food and Drug Administration. She plays a critical role in overseeing the development and implementation of key policy initiatives and provides strategic policy direction to advance FDA’s mission and vision of protecting and promoting public health.


***For full Bio read below!

Thank you to our Sponsors:

SponsorBlock-Annual Dinner 2019.jpg

Table Pricing (Seats 10)

Biocom Member: $2000

Non-Member: $2500

**Purchasing a table of 10 provides you with premium table placement and seating, company name listed in event program and guaranteed seating together for your group of 10.

*If you are having issues purchasing a table of 10, please email Angela Wieszchowski at angelaw@biocom.org

Individual Tickets

Biocom Member: $200

Non-Member: $300

*All individual ticket buyers will be placed into general seating tables. If you anticipate 5 or more colleagues attending as a group, we encourage you to purchase a table of 10 to guarantee seating next to one another.

*Please note: There will be no refunds on purchased tables or general admission tickets.

Price of Admission

Biocom Member

Today’s Price: 200

Important Dates

Amount

Registration before

Registration before

Registration before

Registration cost

200

Refund before 2019-09-26

0

Refund before

Refund Before

Non-Members

Today’s Price: 300

Important Dates

Amount

Registration before

Registration before

Registration before

Registration cost

300

Refund before 2019-09-26

300

Refund before

Refund Before

Biocom Member Table of Ten

Today’s Price: 2000

Important Dates

Amount

Registration before

Registration before

Registration before

Registration cost

2000

Refund before 2019-10-11

0

Refund before

Refund Before

Non-Member Table of Ten

Today’s Price: 2500

Important Dates

Amount

Registration before

Registration before

Registration before

Registration cost

2500

Refund before 2019-10-11

0

Refund before

Refund Before

  • Anna Abram Bio
    Anna Abram is Deputy Commissioner for Policy, Legislation, and International Affairs for the U.S. Food and Drug Administration. She plays a critical role in overseeing the development and implementation of key policy initiatives and provides strategic policy direction to advance FDA’s mission and vision of protecting and promoting public health.

    Ms. Abram is a respected FDA policy thought leader with more than fifteen years of health care policy experience, including more than a decade of working on health care policy in the U.S. Senate. Prior to being appointed to her senior leadership position at FDA, she served as the long-time Health Policy Director and Senior Advisor to Senator Richard Burr at the Senate Health, Education, Labor and Pensions (HELP) Committee, and was actively involved in a range of health care issues under both the Senate HELP and Finance Committees. Her tenure at the Senate HELP Committee was particularly distinguished by her contributions to advancing bipartisan FDA and medical and public health preparedness and response legislation, including securing multiple patient-centered drug and device provisions in the Food and Drug Administration Safety and Innovation Act and 21st Century Cures laws.

    Ms. Abram has played key roles in advancing legislation to support innovation on behalf of patients and that strengthen our nation’s public health. She spearheaded the bipartisan negotiation and enactment of the most significant security enhancements to our nation’s pharmaceutical supply chain in the past 25 years through the Drug Quality and Security Act. She also was instrumental in strengthening our nation’s medical countermeasure work and medical and public health preparedness and response programs through the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013.

    She was previously appointed by President George W. Bush to serve as an Associate Director for the Domestic Policy Council at The White House, where she coordinated the development and implementation of health care policy issues, including food, drug and public health policy. She coordinated the White House-led, interagency policy process to reauthorize the President’s Emergency Plan for AIDS Relief (PEPFAR) in 2008.

    Ms. Abram graduated magna cum laude from the University of Pennsylvania.
     

Registration Closed